Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro
Open Access
- 1 September 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 152 (2) , 223-229
- https://doi.org/10.1038/sj.bjp.0707387
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cilnidipine, a slow‐acting Ca2+channel blocker, induces relaxation in porcine coronary artery: role of endothelial nitric oxide and [Ca2+]iBritish Journal of Pharmacology, 2006
- Raloxifene relaxes rat intrarenal arteries by inhibiting Ca2+ influxAmerican Journal of Physiology-Renal Physiology, 2005
- Raloxifene Relaxes Rat Pulmonary Arteries and Veins: Roles of Gender, Endothelium, and Antagonism of Ca2+ InfluxThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Raloxifene Relaxes Rat Cerebral Arteries In Vitro and Inhibits L-Type Voltage-Sensitive Ca 2+ ChannelsStroke, 2004
- Raloxifene Prevents Cardiac Hypertrophy and Dysfunction in Pressure-Overloaded MiceHypertension, 2004
- From nitric oxide to endothelial cytosolic Ca2+: a negative feedback controlTrends in Pharmacological Sciences, 2003
- Pharmacokinetics of Selective Estrogen Receptor ModulatorsClinical Pharmacokinetics, 2003
- Isoproterenol amplifies 17β-estradiol-mediated vasorelaxation: role of endothelium/nitric oxide and cyclic AMPCardiovascular Research, 2002
- Potentiation of Acetylcholine-lnduced Responses in Freshly Isolated Rabbit Aortic Endothelial CellsJournal of Vascular Research, 1996
- Bradykinin Potentiates Acetylcholine-Induced Responses in Native Endothelial Cells from Rabbit AortaBiochemical and Biophysical Research Communications, 1995